Carter Financial Group, Inc. Astrazeneca PLC Transaction History
Carter Financial Group, Inc.
- $166 Billion
- Q3 2025
A detailed history of Carter Financial Group, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Carter Financial Group, Inc. holds 2,813 shares of AZN stock, worth $251,482. This represents 0.13% of its overall portfolio holdings.
Number of Shares
2,813
Previous 3,200
12.09%
Holding current value
$251,482
Previous $224 Million
3.5%
% of portfolio
0.13%
Previous 0.15%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,502Shares Held
500MCall Options Held
5.64MPut Options Held
3.2M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...